OMNIQ (OMQS) $10.00, Announces Record $25 Million in New Orders, 100% Growth in AI-Based...
OMNIQ Announces Q4 2020 Revenue, up 12% YoY achieving $13 Million in Q4 Revenue; Growth Accelerates in Q1 2021 with a...
Investment Manager With $1 Billion in Assets Under Management, Buys 300 Hapbee (HAPB) Head...
Things that make you go mmmm.
Randy Eisenman is co-founder and managing partner of Satori Capital with more than...
A Medical Technology That Has The Highest Potential Over Any We Follow.
You Must Read This...
New Report on the People Behind EMulate Therapeutics.
200 Million...
Jim Kwik and Kevin Harrington Join Hapbee Technologies (HAPB) Board.
Hapbee Announces Additions to Advisory Board
December 17, 2020
New Advisors Bring Decades of Entrepreneurial ExperienceWellness...
Hapbee (HAPB): The Netflix of Feelings
After 15 years, $70 million spent on R&D, and 350,000+ hours of testing, this "Netflix of Feelings" wearable technology is finally...
Aphex BioCleanse Systems (SNST) Signs European Supply and Private Label Agreement for DermAphex® and...
PITTSFORD, N.Y. , Dec. 16, 2020 /PRNewswire/ -- Aphex BioCleanse Systems, Inc. (OTCPK: SNST) ("Aphex" or "the Company") , a sanitization solutions company focused on the development and distribution...
Scott Donnell Used His Intuition to Launch Hapbee (HAPB). Video.
My next guest, Scott Donnell, who is a serial entrepreneur and CEO of Hapbee (www.hapbee.com), had a knack for business early in...
SinoFresh. One-Stop E-Commerce OTC Health & Wellness Pharmacy
https://youtu.be/axnge8NPH1s
OmniQ (OMQS) Lands Another $6.6 Million in New Orders.
OMNIQ Receives $6.6 Million in New Orders from a Leading U.S. Supermarket Chain for "Touchless" Real-time Data Collection and Analysis Solutions
Dalrada (DFCO) Finally Pops. Up 59% Today.
Up 59% today on news and with 4 million shares trading and counting!
LIVE QUOTE
Latest article
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
